Your browser doesn't support javascript.
loading
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.
Hart, Steven N; Ellingson, Marissa S; Schahl, Kim; Vedell, Peter T; Carlson, Rachel E; Sinnwell, Jason P; Barman, Poulami; Sicotte, Hugues; Eckel-Passow, Jeanette E; Wang, Liguo; Kalari, Krishna R; Qin, Rui; Kruisselbrink, Teresa M; Jimenez, Rafael E; Bryce, Alan H; Tan, Winston; Weinshilboum, Richard; Wang, Liewei; Kohli, Manish.
Afiliação
  • Hart SN; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Ellingson MS; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Schahl K; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Vedell PT; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Carlson RE; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Sinnwell JP; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Barman P; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Sicotte H; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Eckel-Passow JE; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Wang L; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Kalari KR; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Qin R; Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Kruisselbrink TM; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Jimenez RE; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bryce AH; Division of Hematology/Oncology, Mayo Clinic, Mayo Clinic Cancer Center, Scottsdale, Arizona, USA.
  • Tan W; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
  • Weinshilboum R; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Wang L; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Kohli M; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, USA.
BMJ Open ; 6(4): e010332, 2016 Apr 15.
Article em En | MEDLINE | ID: mdl-27084275
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Exoma / Neoplasias de Próstata Resistentes à Castração / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: BMJ Open Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Exoma / Neoplasias de Próstata Resistentes à Castração / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: BMJ Open Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido